Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Synthesis and preliminary evaluation of novel compounds that demonstrate broad host-directed anti-leishmanial activity.

PLoS neglected tropical diseases·2026
Same author

Autoantigen-loaded Polymeric Microparticles associate with B cells and promote tolerogenic antigen presentation in a mouse model of experimental autoimmune encephalomyelitis.

Nature communications·2026
Same author

Turning tumour migration into a therapeutic advantage: Local delivery of chemoattractants for glioblastoma control.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same author

Dual-adjuvant mucosal vaccine leveraging mast cell and TLR9 agonists for protection against poxvirus infection.

RSC pharmaceutics·2026
Same author

Nanoparticle vaccine formulations for dengue virus.

RSC pharmaceutics·2026
Same author

Novel compounds derived from AR-12 that demonstrate host-directed clearance of intracellular <i>Salmonella enterica</i> Serovar Typhimurium.

bioRxiv : the preprint server for biology·2026

Related Experiment Video

Updated: May 11, 2026

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
11:07

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Published on: April 29, 2015

13.2K

Microparticle and nanoparticle-based influenza vaccines.

Luis Ontiveros-Padilla1, Eric M Bachelder1, Kristy M Ainslie2

  • 1Division of Pharmacoengineering & Molecular Pharmaceutics, Eshelman School of Pharmacy, UNC, Chapel Hill, NC, USA.

Journal of Controlled Release : Official Journal of the Controlled Release Society
|October 20, 2024
PubMed
Summary

Annual influenza vaccination is crucial for public health, but yearly reformulation is needed due to viral changes. This review explores strategies for developing broadly reactive influenza vaccines and novel delivery systems.

Keywords:
Broadly reactive antigenComplexesEmulsionsInfluenza vaccinesMetal-based particlesMucosal vaccinationPolymer particlesVaccine deliverymicro/nanoparticles

More Related Videos

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity
10:39

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity

Published on: June 25, 2015

12.5K
Expression and Purification of Virus-like Particles for Vaccination
06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

21.8K

Related Experiment Videos

Last Updated: May 11, 2026

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
11:07

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Published on: April 29, 2015

13.2K
Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity
10:39

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity

Published on: June 25, 2015

12.5K
Expression and Purification of Virus-like Particles for Vaccination
06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

21.8K

Area of Science:

  • Immunology
  • Vaccinology
  • Public Health

Background:

  • Influenza poses a significant global health threat, necessitating annual vaccination due to viral evolution (antigenic drift and shift).
  • Current influenza vaccines require frequent updates, driving the need for more effective and broadly protective vaccine strategies.

Purpose of the Study:

  • To review current U.S. influenza vaccines and production platforms.
  • To discuss approaches for developing broadly reactive influenza vaccines.
  • To explore adjuvant systems and particulate delivery platforms for future vaccine formulations.

Main Methods:

  • Literature review of approved influenza vaccines and emerging technologies.
  • Analysis of immune system components involved in protective responses.
  • Classification of micro- and nano-particulate systems for vaccine delivery.

Main Results:

  • Current vaccine platforms and their limitations are discussed.
  • Various strategies for enhancing vaccine immunogenicity and broad reactivity are presented.
  • Adjuvants and novel particulate delivery systems (micro- and nano-particulate) for parenteral and mucosal vaccination are reviewed.

Conclusions:

  • Developing broadly reactive influenza vaccines is essential to combat seasonal epidemics and potential pandemics.
  • Adjuvants and advanced delivery systems hold promise for improving vaccine efficacy and durability.
  • Understanding immune system components and particulate platforms is key to next-generation influenza vaccine design.